2025-07-19 - Analysis Report
Okay, here's a report summarizing the provided data for Johnson & Johnson (JNJ), compared against the S&P 500 (VOO).

## Johnson & Johnson (JNJ) Stock Analysis

**Ticker:** JNJ
**Company Name:** Johnson & Johnson
**Description:** Johnson & Johnson is a multinational corporation that develops and manufactures pharmaceuticals, medical devices, and consumer packaged goods.

### 1. Performance vs. S&P 500 (VOO)

**Key Numbers:**

*   JNJ Cumulative Return: 20.60%
*   VOO Cumulative Return: 96.72%
*   Absolute Divergence: -80.7%
*   Divergence Range: Max 20.0%, Min -83.0%
*   Relative Divergence: 2.2%

**Analysis:**

JNJ has significantly underperformed the S&P 500.  The cumulative return of JNJ is significantly lower than that of VOO. The relative divergence of 2.2% indicates that JNJ's performance is near the bottom end of its historical divergence range compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2015-2017  | 28.0%  | 56.1%  | -1.0%   | -0.0   | 336.2  |
| 2016-2018  | 8.0%   | 56.6%  | -10.0%  | 0.0    | 310.5  |
| 2017-2019  | 18.0%  | 56.6%  | -12.0%  | 0.7    | 351.0  |
| 2018-2020  | 12.0%  | 59.2%  | -8.0%   | 0.3    | 378.7  |
| 2019-2021  | 32.0%  | 59.6%  | -16.0%  | 0.2    | 411.6  |
| 2020-2022  | 7.0%   | 61.4%  | 5.0%    | 0.2    | 425.0  |
| 2021-2023  | -15.0% | 61.4%  | -33.0%  | 0.4    | 377.1  |
| 2022-2024  | -35.0% | 61.4%  | -61.0%  | 0.3    | 348.0  |
| 2023-2025  | -7.0%  | 70.1%  | -55.0%  | 0.2    | 393.9  |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate shows fluctuating performance, with negative growth in recent periods.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant potential for losses.
*   **Alpha:**  Alpha is largely negative, implying JNJ has underperformed the market on a risk-adjusted basis.
*   **Beta:** Beta values are generally low, suggesting JNJ's price is not strongly correlated with the overall market (S&P 500).

### 2. Recent Stock Price Movement

**Key Numbers:**

*   Current Price: \$163.70
*   Previous Close: \$162.98
*   Change: 0.44%
*   5-Day Moving Average: \$160.69
*   20-Day Moving Average: \$155.77
*   60-Day Moving Average: \$154.58

**Analysis:**

The stock price is trading above its 5, 20, and 60-day moving averages, suggesting a recent upward trend.  The relatively small increase from the previous close (0.44%) indicates moderate positive momentum.

### 3. Market Risk Indicators and Expected Return

**Key Numbers:**

*   Market Risk Indicator (MRI): 0.3399 (Low Risk)
*   RSI: 75.51
*   PPO: 0.63
*   Hybrid Signal: cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   Recent (20-day) Relative Divergence Change: -1.0 (Negative - Short-term decline)
*   Expected Return: -1354.0%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a "Low Risk" environment for JNJ.
*   **RSI:** The RSI is high (75.51), indicating that JNJ may be overbought and prone to a correction.
*   **PPO:** The PPO is positive (0.63), which suggests a short-term bullish trend but near zero
*   **Hybrid Signal:** The hybrid signal recommends buying 80% with caution due to MRI, which indicates a low risk of investment
*   **Divergence Change:** The negative change in relative divergence suggests a short-term decline relative to the S&P 500.
*   **Expected Return:** The highly negative expected return of -1354.0% should be regarded as outliers or errors.

### 4. Recent News & Significant Events

*   **July 15, 2025:** JNJ has made headlines due to major business developments, regulatory changes, or market events.
*   **July 16, 2025:** Analysts are discussing JNJ's recent performance and its outlook.
*   **July 19, 2025:** JNJ's stock has shown notable volatility.
*   **July 17, 2025:** Market experts highlight both risks and opportunities for JNJ.

**Analysis:**

Recent news suggests that JNJ is experiencing volatility and is subject to market and regulatory scrutiny. Investors should closely monitor news and company announcements for more specific details.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-04-23 | 4.57 | \$21.89B    |
| 2024-10-23 | 1.12 | \$22.47B    |
| 2024-07-25 | 1.95 | \$22.45B    |
| 2024-05-01 | 1.35 | \$21.38B    |
| 2025-04-23 | 1.35 | \$21.38B    |

**Analysis:**

EPS is unstable in the last 5 quarters
Revenue is fairly constant in the last 5 quarters

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-03-31 | \$21.89B   | 66.40%        |
| 2024-12-31 | \$22.52B   | 68.35%        |
| 2024-09-30 | \$22.47B   | 69.01%        |
| 2024-06-30 | \$22.45B   | 69.40%        |
| 2024-03-31 | \$21.38B   | 69.55%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE    |
|------------|------------|--------|
| 2025-03-31 | \$78.11B   | 14.08% |
| 2024-12-31 | \$71.49B   | 4.80%  |
| 2024-09-30 | \$70.16B   | 3.84%  |
| 2024-06-30 | \$71.54B   | 6.55%  |
| 2024-03-31 | \$70.02B   | 4.65%  |

**Analysis:**

*   **Revenue:**  Revenue is relatively stable across the quarters.
*   **Profit Margin:**  Profit margins are very high, but has been slightly decreasing recently.
*   **Equity:**  Equity has grown over the last year.
*   **ROE:** ROE is volatile.

### 7. Overall Summary

Johnson & Johnson (JNJ) has significantly underperformed the S&P 500. While recent price action shows a slight upward trend, the RSI suggests the stock may be overbought. Financial data reveals stable revenue but declining profit margins and volatile ROE. Recent news points to volatility and significant events affecting the stock. The exceptionally negative expected return is suspicious and should be further investigated.

**Recommendation:**

Given the underperformance relative to the S&P 500, potentially overbought conditions, and negative long-term expected return (assuming no errors in the data), caution is advised. Investors should closely monitor news, earnings reports, and further investigate the reasons for the extremely negative expected return before making any investment decisions. Consider alternative investment opportunities with stronger growth potential.
